Abstract: Methods, systems, and devices for controlling a serial arc fault in an electrical circuit are disclosed. In some embodiments, the methods include the following: a. measuring a current in the circuit; b. determining whether the current is below a predetermined value; c. if the current is below ten percent of the predetermined value, determining whether a countdown timer value indicated by a cell pointer value is equal to zero; d. if the countdown timer value is equal to zero, starting a countdown timer, advancing the cell pointer value by one, and restarting the method at step a.; e. if the countdown timer value is not equal to zero, determining whether the interruptions in the current are periodic; f. if the interruptions in the current are not periodic, checking whether an arc event countdown timer is running; and g. if the arc event countdown timer is running, tripping a circuit breaker.

Abstract: A latch-based integrated circuit random access memory having selectable bit write capability that is less susceptible to disturbing data stored in unselected bits during write operations by utilizing an inhibit signal to block writing of the unselected bits.

Abstract: Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.

Abstract: An improved refractometer for automatically determining the refractive index of a test subject by using principles embodied in Brewster's Angle, the refractometer comprising a light source, a light detector, a subject mount for securing the test subject to the device, a positioning device to orient the light source and light detector to the subject such that the angles of the light source and light detector to the subject are substantially identical, a data gathering device to automatically retrieve relevant data regarding the angles of the light source and light detector to the subject and the light intensity of the reflected light, and a computational device to process the data using algorithms taking into account the principles embodied in Brewster's Angle and/or Fresnel Equations in order to arrive at the refractive index of the test subject.

Abstract: A latch-based integrated circuit random access memory having selectable bit write capability that is less susceptible to disturbing data stored in unselected bits during write operations by utilizing an inhibit signal to block writing of the unselected bits.

Abstract: Systems and methods for automated analysis and targeting of digital media based upon spoken topic or criterion recognition of the digital media are provided. Pre-specified criteria are used as the starting point for a top-down topic or criterion recognition approach. Individual words used in the audio track of the digital media are recognized only in context of each candidate topic or criterion hypothesis, thus yielding greater accuracy than two-step approaches that first transcribe speech and then recognize topic based upon the transcription.

Abstract: This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of A? related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Abstract: Disclosed are processes for preparing monomer complexes that include contacting 2,3,5,6-tetraaminopyridine free base in water with 2,5-dihydroxy terephthalic acid dipotassium salt to form an aqueous mixture, and adjusting the pH of the aqueous mixture to within the range of from about (3) to about (5) to precipitate the monomer complex. Processes of polymerizing the monomer complexes, polyareneazoles, filaments and yarns are also disclosed.

Abstract: Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.

Abstract: This invention relates to novel compounds having the structural formula I below and to their pharmaceutically acceptable salts, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Abstract: A process for the preparation of diaminodinitropyridine or diaminodinitrobenzene by contacting an aminopyridine or aminobenzene with oleum and nitric acid, wherein the improvement comprises adding at least about 1% molar excess of nitric acid, based upon the aminopyridine or aminobenzene, with stirring for at least two hours to form first the intermediate sulfonic acid, and then diaminodinitropyridine or diaminodinitrobenzene, and use of such products in the preparation of rigid rod polymers is disclosed.

Abstract: A continuous process for producing hexafluoroisopropanol is provided which comprises contacting hexafluoroacetone with hexafluoroisopropanol and hydrogen to produce a liquid feed stream; introducing the liquid feed stream to a reactor containing an immobilized hydrogenation catalyst to convert the hexafluoroacetone to hexafluoroisopropanol and provide a product stream; and recovering at least a portion of the hexafluoroisopropanol from the product stream. Preferably a portion of the product stream is recycled. The reactor can be a packed bed or stirred tank reactor.

Abstract: Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.

Abstract: This invention relates to novel compounds having the structural formula Ia or formula Ib below: (Ia, Ib), and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of A? related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Abstract: Methods and apparatus to pre-compensate for in-phase/quadrature (I/Q) distortion in quadrature transmitters are disclosed. A disclosed example method comprises coupling a portion of an analog baseband in-phase signal to an analog baseband quadrature signal through an impedance, and selecting a resistance value for the impedance to pre-distort the analog baseband quadrature signal to compensate for an error introduced by modulation of the analog baseband in-phase signal and the analog baseband quadrature signal.

Abstract: An interval timer combining the features of a practice timer, means of measuring date and metronome into a single device for the purpose of measuring, recording, and displaying practice records over a period of weeks or months. During the measuring of practice time, the device may complement the passage of time by the use of lights, sounds, or vibrations. It features a display screen that can indicate total time practiced, current chronological time and date, and a record of practice accomplished over a period of chronological time. The device may also accommodate interchangeable face plates of electronic icons for user personalization of the device. An enhanced version may include means for displaying assignment and practice information.

Abstract: According to an embodiment, a method and system for color calibration in a three-dimensional multi-color laser scanning system is disclosed. An object may be scanned with the scanning system, which scans the object with color laser heads. Laser intensities, corresponding to laser intensity values, may be received from the scanned object. Three different calibration targets are used to setup a field of view (FOV) calibration profile due to scanning position changes, a surface normal calibration profile due to surface normal direction changes, and a color reflectance calibration profile due to color reflectance changes. After compensating for laser power drift fluctuations, the laser intensity values may be further compensated for field of view scanning position changes and surface normal direction changes using the field of view calibration profile and surface normal calibration profile.

Abstract: This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

Abstract: Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.

Abstract: Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.